Biorelate

Manchester, United Kingdom

Biorelate provides biomedical research services.

$7.8M raised

Nov 2022

Series A

Big Data Biotechnology Health Care Life Science Medical

Top Investors

Maven Capital Partners Triple Point Ventures YFM Equity Partners Northern Powerhouse Investment Fund GM&C Life Sciences Fund

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Biorelate

How much funding has Biorelate raised?

Biorelate has raised $7.8M in total funding. The most recent round was Series A. The last funding was announced in November 2022.

Who are Biorelate's investors?

Biorelate's investors include Maven Capital Partners, Triple Point Ventures, YFM Equity Partners, Northern Powerhouse Investment Fund, GM&C Life Sciences Fund.

Where is Biorelate headquartered?

Biorelate is headquartered in Manchester, United Kingdom.

What does Biorelate do?

Biorelate provides biomedical research services.

What stage is Biorelate at?

Biorelate is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 29, 2022.

MLA

"Biorelate — Funding & Investors." VCBacked, November 29, 2022, https://www.vcbacked.co/company/biorelate. Accessed July 2, 2026.

APA

VCBacked. (2022). Biorelate — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/biorelate

Wikipedia (cite web)

{{cite web |title=Biorelate — Funding & Investors |url=https://www.vcbacked.co/company/biorelate |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 29, 2022.

Similar Companies in Big Data